Compare IDEXX Laboratories, Inc. (IDXX) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Lockheed Martin Corporation — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Lockheed Martin Corporation trades at $509.59 (market cap $117.22B). The key difference: Lockheed Martin Corporation is far larger — about 2.9× IDEXX Laboratories, Inc.'s market cap, and Lockheed Martin Corporation pays a 2.72% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Lockheed Martin Corporation for 86 Days on average.
| IDXX | LMT | |
|---|---|---|
Market Cap | $40.43B | $117.22B |
Volume | 692,164 | 1,101,121 |
Sector | Health | Industrials |
52-Week High | $766.68 | $676.70 |
52-Week Low | $504.70 | $439.19 |
Typical Hold Time | 46 Days | 86 Days |
Enterprise Value | $41.32B | $133.96B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Lockheed Martin (LMT) trades at $507.89, up 1.74% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS beat but missed in Q4 2025 and Q1 2026, with revenue growth from $71B in 2024 to $75B in 2025. Analyst consensus is strongly bullish with 59% buy ratings and a $635.33 price target, representing 25% upside. Recent news highlights dividend increases for 23 straight years and strategic AI partnerships through Skunk Works innovation.
LMT offers attractive valuation with P/E of 18.73 and strong defense contract backlog, though recent earnings misses and rising debt-to-asset ratio to 36.44% pose execution risks. The stock presents value opportunity amid sustained Pentagon spending, but investors should monitor contract performance and interest rate sensitivity given $19.63B long-term debt.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
